Ertapenem is an antibiotic commonly used to treat a broad spectrum of infections and is part of a broader class of antibiotics called carbapenems. Unlike other carbapenems, ertapenem has a longer half-life and thus only has to be administered once a day. Previously, a physiologically-based pharmacokinetic (PBPK) model was developed to investigate the uptake, distribution, and elimination of ertapenem following a single one gram dose in normal height, normal weight males. Due to the absorption properties of ertapenem, the amount of fat in the body can influence how the drug binds, how quickly the drug passes through the body, and thus how effective the drug might be. Thus, we have revised the model so that it is applicable to males and females of differing body mass index (BMI). Simulations were performed to consider the distribution of the antibiotic in males and females with varying body mass indexes. These results could help to determine if there is a need for altered dosing regimens in the future.
Citation: Michele L. Joyner, Cammey Cole Manning, Whitney Forbes, Valerie Bobola, William Frazier. Modeling Ertapenem: the impact of body mass index on distribution of the antibiotic in the body[J]. Mathematical Biosciences and Engineering, 2019, 16(2): 713-726. doi: 10.3934/mbe.2019034
Related Papers:
[1]
Ruyu Yan, Jiafei Jin, Kun Han .
Reinforcement learning for deep portfolio optimization. Electronic Research Archive, 2024, 32(9): 5176-5200.
doi: 10.3934/era.2024239
[2]
Duhui Chang, Yan Geng .
Distributed data-driven iterative learning control for multi-agent systems with unknown input-output coupled parameters. Electronic Research Archive, 2025, 33(2): 867-889.
doi: 10.3934/era.2025039
[3]
Yufei Duan, Xian-Ming Gu, Tingyu Lei .
Application of machine learning in quantitative timing model based on factor stock selection. Electronic Research Archive, 2024, 32(1): 174-192.
doi: 10.3934/era.2024009
[4]
Longchao Da, Hua Wei .
CrowdGAIL: A spatiotemporal aware method for agent navigation. Electronic Research Archive, 2023, 31(2): 1134-1146.
doi: 10.3934/era.2023057
[5]
Mengke Lu, Shang Gao, Xibei Yang, Hualong Yu .
Improving performance of decision threshold moving-based strategies by integrating density-based clustering technique. Electronic Research Archive, 2023, 31(5): 2501-2518.
doi: 10.3934/era.2023127
[6]
Qianpeng Xiao, Changbin Shao, Sen Xu, Xibei Yang, Hualong Yu .
CCkEL: Compensation-based correlated k-labelsets for classifying imbalanced multi-label data. Electronic Research Archive, 2024, 32(5): 3038-3058.
doi: 10.3934/era.2024139
[7]
Ilyоs Abdullaev, Natalia Prodanova, Mohammed Altaf Ahmed, E. Laxmi Lydia, Bhanu Shrestha, Gyanendra Prasad Joshi, Woong Cho .
Leveraging metaheuristics with artificial intelligence for customer churn prediction in telecom industries. Electronic Research Archive, 2023, 31(8): 4443-4458.
doi: 10.3934/era.2023227
[8]
Jian Guan, Fei Yu, Hongrun Wu, Yingpin Chen, Zhenglong Xiang, Xuewen Xia, Yuanxiang Li .
Dynamic allocation of opposition-based learning in differential evolution for multi-role individuals. Electronic Research Archive, 2024, 32(5): 3241-3274.
doi: 10.3934/era.2024149
[9]
Li Sun, Bing Song .
Feature adaptive multi-view hash for image search. Electronic Research Archive, 2023, 31(9): 5845-5865.
doi: 10.3934/era.2023297
[10]
Shizhen Huang, Enhao Tang, Shun Li, Xiangzhan Ping, Ruiqi Chen .
Hardware-friendly compression and hardware acceleration for transformer: A survey. Electronic Research Archive, 2022, 30(10): 3755-3785.
doi: 10.3934/era.2022192
Abstract
Ertapenem is an antibiotic commonly used to treat a broad spectrum of infections and is part of a broader class of antibiotics called carbapenems. Unlike other carbapenems, ertapenem has a longer half-life and thus only has to be administered once a day. Previously, a physiologically-based pharmacokinetic (PBPK) model was developed to investigate the uptake, distribution, and elimination of ertapenem following a single one gram dose in normal height, normal weight males. Due to the absorption properties of ertapenem, the amount of fat in the body can influence how the drug binds, how quickly the drug passes through the body, and thus how effective the drug might be. Thus, we have revised the model so that it is applicable to males and females of differing body mass index (BMI). Simulations were performed to consider the distribution of the antibiotic in males and females with varying body mass indexes. These results could help to determine if there is a need for altered dosing regimens in the future.
1.
Introduction
In this paper, we investigate whether financial innovations in precious metals can be exploited to deliver hedging effectiveness for pandemic-induced risks in the Asia-Pacific market during the COVID-19 pandemic. We seek protection against the pandemic-induced uncertainty in financial innovations captured as exchange traded funds in precious metals in line with similar evidences on financial innovations in commodities to hedge market risks (Sukcharoen et al., 2015; Arunanondchai et al., 2019; Latunde et al., 2020), however, we differ from these studies as our analyses also accommodate the COVID-19 effects by partitioning our data sample into the pre-COVID-19 and COVID-19 samples. We rely on the Exchange traded funds (ETFs hereafter) as our choice of financial innovations since they constitute innovative investment funds that allow for cost-effective hedging benefits through passive investments in baskets of assets rather than trading in the actual indexes containing the physical assets (Marszk and Lechman, 2018; Naeem et al., 2020; Ozdurak and Ulusoy, 2020; Sakarya and Ekinci, 2020). In addition to being cost-effective alternatives to trading in physical assets, these investment options track well the performances of the underlying assets composed in the ETF indexes with negligible tracking errors (extensive discussions on the nature, origin and features of ETFs as financial innovations can be found in Gao (2001), Haslem (2003), Hehn (2005), Harper et al. (2006), Ferri (2009), Tari (2010), Chelley-Steeley and Park (2011), Charupat and Miu (2013), Lechman and Marszk (2015), and Dannhauser (2017), among others).
We attempt two contributions to the growing literature on pandemic-financial markets nexus bothering on the choice of proxy for financial innovation and Asia-Pacific financial markets. The first contribution seeks to explore financial innovations in precious metals for risk hedging purposes particularly during the COVID-19 pandemic. This effort allows us to contribute to two sub-literature: one, those that limit the search for alternative instruments to mutual funds, cryptocurrency, Islamic bonds, etc. (Balcilar et al., 2016; Reboredo and Naifar, 2017; Maghyereh et al., 2018; Selmi et al., 2018; Olson et al., 2019; Shahzad et al., 2019; Okorie and Lin, 2020; Urom et al., 2020) and two, those that restrict the hedging role to physical precious metals (Beckmann et al., 2018; Junttila et al., 2018; Salisu et al., 2019; Huynh, 2020) both of which do not consider the COVID-19 effects.1 Thus, we consider the hedging potential of an array of precious metals as alternative options to equities that seem to more vulnerable to the current pandemic (Baker et al., 2020; Salisu and Vo, 2020; Salisu et al., 2020; OECD, 2020; Li et al., 2020; Salisu and Sikiru, 2020; Sharma, 2020). We prefer financial innovations in precious metals because they offer flexible and cost-effective means to invest in precious metals (which are themselves established safe assets) without concerns about storage costs (Kraft, 2012; Leung and Ward, 2015; Kaur and Singh, 2020). We also build on the existing evidences from Lau et al. (2017) and Cheng et al. (2018) that financial innovations in the gold market can replace physical gold to hedge oil and currency market risks. Going forward, we probe whether same can be shown for precious metals in general including gold, silver, platinum and palladium against pandemic-induced risks.
On the second contribution, our choice of Asia-Pacific financial markets is hinged on a number of justifications. One, the region is labelled as the region of the current pandemic and therefore inherent fear seems to have accentuated the economic consequences of the COVID-19 pandemic in the region (Salisu and Akanni, 2020; Salisu and Vo, 2020). For instance, during the early days of the pandemic, Salisu and Vo (2020) report contractions in the stock markets of Australia, South Korea, Hong Kong and China similar to occurrences in the United States, a major worst-hit country by the pandemic. Two, the Asia Pacific countries are highly connected through trade and financial flows, hence, the pandemic shocks are expected to reverberate through the region, thus make hedging against such uncertainties even more desirable. Three, evidences on past crises show that spillovers have deepened interactions among the Asia-Pacific stock markets (Kim, 2005 for evidence on the 1997 Asian crisis and Liu, 2014; Hengchao and Hamid, 2015; Lin, 2015; Chow, 2017; Ahmed and Huo, 2019 for evidences on the global financial crisis which further show increasing roles of China, Japan and the US in the region).
In the empirical analysis, we employ the Multivariate Generalized Autoregressive Conditional Heteroscedastic (M-GARCH) framework to examine the hedging effectiveness of financial innovations. The choice of this modelling technique is informed by the preliminary tests of the data as well as evidence in the extant literature showing its fitness for capturing conditional heteroscedasticity and serial correlation in the data (Arouri and Nguyen, 2010; Arouri et al., 2011; Salisu and Mobolaji, 2013; Salisu and Oloko, 2015; Salisu et al., 2020; Sikiru and Salisu, 2021). The suitability of the MGARCH model further lies in accommodating time-variation as well as volatility in the hedging analysis relative to competing models such as Vector Autoregressive model and its variants (Lypny and Powalla, 1998; Lee et al., 2005; Yang and Lai, 2009).
The highlights from this study show that investment in financial innovations in gold market presents optimal portfolio hedging alternative and provide premium for Asia Pacific investors. However, the impact of the financial crisis induced by the COVID-19 pandemic shrinks the hedging performance when compared with the period before it. Following this background, we offer some preliminary analyses in Section 2 to guide the choice of the model. In Section 3, we render the modelling framework and implements same in Section 4 with detailed discussion of findings. We conclude the paper in Section 5 with relevant policy implications.
2.
Data description and preliminary analysis
Our empirical analysis is based on equities for 13 Asia-Pacific countries as well as the region aggregate, and 4 prominent precious metals ETFs. The regional aggregate is the iShares Core MSCI Pacific ETF which objective is to track the investment composition of the Pacific region large, mid and small capitalization equities. In a similar vein, the country specific equities are also selected from the MSCI family because of their characteristics of tracking investment results of equity market index for each of the countries under consideration. Besides, the funds generally invest at least 90% of assets in the securities of the underlying market index and in depositary receipts representing securities in the underlying index. The daily ETF series are collected for the periods between May 2015 and October 2020 from Yahoo Finance database (www.finance.yahoo.com). To evaluate the impacts of the COVID-19 outbreak as discussed in the introduction, the data sample is divided into three sub-samples, full, before and during the outbreak of COVID-19 pandemic.
We render some descriptive statistics, which consist of the mean, maximum, minimum, standard deviation, skewness and kurtosis using the equity and commodity ETF return series. The daily returns are computed as the natural log of the ratio of two successive prices. The statistics are summarized in Table 1. The mean value of returns for the countries reveal positive values only for four of the countries, namely, Canada, Japan, South Korea and Taiwan and the rest return with negative average values. Bearing the differences in the average values, the distributions of the daily return series appear to have similar spread with the standard deviation values with Canada and Indonesia having the lowest and highest values respectively. Similarly, they have similar skewness features as all are negatively skewed and follow leptokurtic distribution (i.e. kurtosis value > 3). Among the precious metals' financial innovations, all except platinum display positive average returns in the period under investigation. Likewise, the trio (of gold, silver and palladium) except platinum are positively skewed. Hence, given the distributional differences, we may expect the precious metals ETFs to be negatively correlated with the equities ETFs in which case the former may be expected to provide the much needed hedging potentials.
We probe the foregoing further in the graphical analyses that follow the descriptive statistics. Figures 1a to 1d depict the graphs of the co-movements between the returns for precious metals and equities ETF for each of the countries in the Asia-Pacific region. The idea behind these graphs is that financial innovation in a market (precious metals markets, in the current case) can only hedge risks in another market if the returns on traded funds in both markets are negatively correlated (Baur and Lucey, 2010). The graphs (in Figures 1a to 1d), divided into four segments each for the individual precious metals' financial innovations, show evidence of a negative relationship between each of the precious metals and country's equities. These negative correlations are more pronounced in the segments for financial innovations in gold, silver and palladium, thereby corroborating the previous preliminary findings and therefore indicating that financial innovation in platinum may not possess strong hedging power to cover the Asia-Pacific stock market risks.
Figure 1.
Co-movements between precious metals ETFs and Asia-Pacific equities ETFs returns: (a) Gold, (b) Silver, (c) Platinum, and (d) Palladium.
Note: The figures here presented are divided into four segments (a to d) each for the four precious metals ETF plotted against the overall Asia-Pacific and country specific equity stock ETFs.
Next, we conduct formal pre-tests as discussed in the methodology section. The obtained estimates from the formal pre-tests are categorized into two and they are both crucial in the determination of the appropriate VARMA-GARCH model2 as well as in the estimation of the optimal portfolio weights and hedging ratios between each of the considered equities and commodities ETFs. The first set of preliminary statistics is conducted to establish the appropriateness of the VARMA-GARCH model, and the two tests conducted include the serial correlation and autocorrelation tests. On the other hand, the asymmetric effect test and the constant conditional correlation tests are conducted to evaluate the presence of asymmetric effect, and the choice between constant and dynamic specification of the conditional correlations. The serial correlation test is conducted using Ljung-Box Q-statistics, while we employ the ARCH-LM test for the conditional heteroscedasticity tests. We evaluate the asymmetric effects using the Engle and Ng sign and bias tests while the Engle-Sheppard test is used to evaluate the constant conditional correlation (CCC). All the results are summarised in Tables 2 and 3.
Table 2.
Conditional heteroscedasticity and autocorrelation tests.
Full sample
Before COVID-19
During COVID-19
ARCH5
ARCH10
LB5
LB10
LB52
LB102
ARCH5
ARCH10
LB5
LB10
LB52
LB102
ARCH5
ARCH10
LB5
LB10
LB52
LB102
Region
22.0a
14.2a
7.9a
18.1b
122.8a
176.0a
4.1a
2.6a
3.3
4.9
21.6a
31.6a
8.0a
4.9a
11.7b
18.3b
40.4a
52.0a
Australia
55.8a
30.2a
9.8b
21.2b
334.7a
424.3a
5.5a
5.4a
9.4c
17.3b
27.3a
56.0a
18.4a
9.5a
10.8b
22.1a
84.4a
101.0a
Canada
20.5a
12.1a
9.7b
14.3
131.6a
222.4a
1.8
3.4a
0.5
7.3
9.3
40.5a
6.3a
3.3a
11.1b
16.0c
35.3a
50.1a
China
1.8
1.4
4.3
10.0
10.1c
14.5
2.0c
1.6
0.9
6.5
10.2c
16.5c
0.9
1.1
5.8
7.4
5.6
7.5
Hong Kong
3.4a
2.5a
4.5
9.1
19.6a
28.7a
5.0a
2.9a
1.5
4.0
23.7a
27.9a
1.6
2.0b
3.3
7.8
9.6c
14.4
India
1.6
0.9
11.9b
20.8b
9.0
10.8
0.1
0.1
1.9
5.5
0.3
0.4
16.3a
9.5a
8.1c
18.9b
78.0a
104.9a
Indonesia
20.9a
12.4a
3.6
6.9
156.0a
262.2a
4.5a
4.2a
0.4
8.3
25.2a
53.2a
4.4a
2.6a
3.0
9.2
34.7a
53.8a
Japan
7.8a
5.7a
5.5
10.4
45.1a
78.0a
2.9b
1.6
5.8
7.4
14.9b
17.5c
6.1a
4.9a
6.5
10.4
33.5a
56.2a
South Korea
33.3a
17.7a
6.6
16.8c
194.5a
263.8a
1.1
1.1
2.2
7.1
5.7
11.8
11.5a
6.8a
6.0
13.9
61.0a
73.9a
Malaysia
0.1
0.1
3.7
8.7
0.6
0.6
0.1
0.0
10.3b
18.7b
0.3
0.4
6.2a
3.8a
16.2a
22.3a
38.1a
39.7a
Philippines
22.3a
13.5a
17.1a
23.0a
127.0a
180.4a
3.3a
1.8c
1.6
6.6
16.9a
18.6b
6.9a
4.4a
11.5b
18.6b
32.1a
43.5a
Singapore
13.7a
7.1a
7.3
12.7
81.5a
94.1a
4.3a
2.5a
8.9c
16.8c
20.7a
26.3a
13.0a
8.8a
5.5
12.0
58.5a
62.2a
Thailand
28.1a
17.4a
34.9a
49.5a
187.6a
273.1a
0.8
0.8
8.3c
18.3b
3.8
8.6
5.8a
3.8a
15.3a
19.9b
38.0a
51.3a
Taiwan
4.4a
3.1a
7.7c
15.1c
27.1a
39.5a
4.4a
2.6a
4.7
15.1c
20.6a
26.8a
5.3a
4.2a
10.8b
15.9c
29.9a
36.6a
Commodities
Gold
13.1a
6.6a
3.7
6.5
62.4a
72.6a
11.8a
5.9a
5.9
10.3
562a
64.0a
3.9a
2.6a
8.0c
10.8
13.8b
19.7b
Silver
10.1a
5.9a
3.7
5.9
54.0a
79.3a
13.5a
7.3a
2.3
6.8
57.8a
76.2a
0.6
0.6
5.4
11.9
3.2
6.2
Platinum
6.4a
3.2a
6.0
6.4
35.4a
37.4a
7.0a
3.5a
3.0
5.2
33.9a
34.2a
0.5
0.3
7.6
9.4
3.3
3.7
Palladium
2.9b
4.5a
13.9a
20.5b
16.1a
53.1a
0.8
1.5
10.3b
13.8
4.2
15.0
0.3
0.6
9.3c
13.1
1.8
8.1
Note: ARCH5 and ARCH10 of conditional heteroscedasticity indicate the ARCH LM tests at 5 and 10 lags respectively. The LB and LB2 of autocorrelations follow the Ljung-Box tests conducted at 5 and 10 lags. The null hypothesis for the ARCH LM test is that the series has no ARCH effects (that is, it is not volatile) while LB test for null hypothesis is that the series is not serially correlated. The superscripts a, b and c indicate statistical significance respectively at 1%, 5% and 10% levels.
Note: ES test is the Engle-Sheppard CCC χ22 test. The superscripts a, b and c respectively indicate statistical significance for 1%, 5% and 10% levels; Region denotes the Asia-Pacific Region Equity; AUS is an acronym for Australia; CAN for Canada; CHN: China, HNK: Hong Kong; IND: India; IDN: Indonesia; JPN: Japan; KOR: South Korea; MLY: Malaysia; PHI: Philippines; SGP: Singapore, THA: Thailand; and TWN: Taiwan. The precious metals ETFs are abbreviated as GLD, SLV, PLT and PLD, respectively denoting Gold, Silver, Platinum and Palladium.
2 The term VARMA-GARCH conventionally implies a multivariate GARCH model specified in the form of Vector (V) Autoregressive (AR) Moving Average (MA) form where both the ARCH and GARCH terms respectively mimic the AR and MA terms. For relevant applications of this methodology for hedging purpose, see Salisu and Oloko(2015a, b); Salisu et al. (2020); Sikiru and Salisu (2021), among others.
The results of the ARCH-LM tests indicate that the returns exhibit conditional heteroscedasticity with the hypothesis of no ARCH effects rejected. This outcome validates the choice of GARCH-based models to accommodate the presence of heteroskedasticity in the estimation process for the variables of interest. Similarly, the statistical significant estimates for both the correlogram Q-statistic and its squared version confirm the presence of serial correlation in all the return series under consideration, both at 5 and 10 lag orders. Thus, the consideration of a dynamic model like the VARMA-GARCH which accommodates dynamic effects both in the mean and variance equations is justified. Finally, the results of the Engle and Ng sign bias tests and Engle-Sheppard tests as summarized in Table 3 confirm mixed evidences for both symmetric and asymmetric effects between the equity ETF returns and precious metals ETF. For instance, the significant sign and joint bias results for Indonesia in the full sample and before COVID periods suggest that the effect of positive and negative shocks in the Indonesian equity stock ETF is significantly different confirming that the presence of asymmetry in the volatility process. On the other hand, Japan and Korea exhibit only positive bias respectively in the full sample and during COVID-19 periods. The results also show mixed evidence of constant and dynamic conditional correlations in the full-sample, pre-COVID and COVID-19 periods. Specifically, the equities for Australia, China, Hong Kong, Japan, Korea and Taiwan, all exhibit dynamic conditional correlations with the Palladium in the COVID-19 sample. This outcome further underscores the COVID effect in the behavior of financial markets as espoused in the emerging literature examining the connection between the pandemic and financial markets (Salisu et al., 2020; Sikiru and Salisu, 2021).
3.
The model
Following the formal preliminary tests discussed in the preceding section, this study employs the GARCH-based VARMA model proposed by Ling and McAleer (2003). Additionally, we favour this methodology owing to its ability to capture interdependencies among financial markets with or without asymmetric shock effects (Salisu and Mobolaji, 2013; Salisu and Oloko, 2015; Al-Maadid et al., 2016; Salisu et al., 2020; Sikiru and Salisu, 2021).3 Based on the outcome of the sign bias and Engle-Shephard tests, we formulate a VARMA-GARCH model that reflects the same as follows:
3 A similar methodology was recently employed by Salisu et al. (2020) and Sikiru and Salisu (2021) to analyze possible hedging strategies during COVID-19 pandemic. Our study further adds to the emerging literature on the possible mitigation strategies against the risks associated with the current pandemic by considering ETFs as alternative options.
rstkt=φstk1+φstk1rstkt−1+θstk1rfint−1+ϵstkt
(1)
rfint=φfin2+φfin2rfint−1+θfin2rstkt−1+ϵfint
(2)
where rstkt is for the returns on stocks (stk); rfint denotes the returns on each of the financial innovations (fin) related to precious metals; φstk and φfin are constant terms; φstk and φfin are coefficients of the lagged terms of own-returns; θstk and θfin are coefficients of lagged terms of returns measuring cross-return spillovers between the two financial assets; ϵstkt and ϵfint are independently and identically distributed errors while the superscripts define the asset classes. The superscripts 1 and 2 denote the parameters for stock returns and financial innovation returns, respectively. The conditional variance equations which provide the estimates of the volatility and shock spillover effects between the two asset classes are specified in Equations (3) and (4) as:4
4 The specifications in Equations (3) and (4) follow the asymmetric version. The symmetric version of the model excludes the own asymmetric effects as part of the independent variables in both equations.
where ht is the conditional variance while ϵ2t is a measure of shock. Therefore, the conditional variance equations show that conditional variance for each sector is dependent on its immediate past values and innovations as well as past values of conditional variance and innovations from the other sector. The conditional covariance equation which is assumed to follow the constant conditional correlations is expressed as:
hSFt=ρSF×√hstkt×√hfint
(5)
where ρSF is the constant conditional correlations between equity and financial innovations in precious metals while SF distinctly denotes Stock returns (S) and financial innovations (F).
In line with the objective of this paper, the estimated coefficients obtained from the VARMA-GARCH model are employed to evaluate the optimal weights and hedging ratios between Asia Pacific Equities and Precious metals financial innovations. The optimal portfolio weights (OPW) establish the proportion of investments in both categories of financial innovations be included in a portfolio to ensure optimality. Significant volatility spillovers between two investment assets in a portfolio may indicate that investments in the two assets are volatile and susceptible to risk and uncertainty. Hence, investors engage in hedging to mitigate such associated risks through investment in futures contract without jeopardising expected future returns. The expected returns are assumed to be zero to avoid forecasting problems, thus, making the problem similar to estimating risk-minimizing portfolio weights (Kroner and Ng, 1998, Shrydeh et al., 2019). Following the approach proposed in Kroner and Ng (1998) and Arouri et al. (2011), we construct the optimal portfolio weight of holding the two assets using the conditional variance and covariances obtained in Equations (1) and (2) as:
where ϖSC,t denotes the weight of a given precious metal ETF in a one-dollar equity/precious metal ETF investment portfolio at time t. On the other hand, the proportion assigned to equity assets is calculated as 1−ϖSC,t while ht is the conditional covariance at time t. The optimal hedge ratios (OHR) (denoted as αSC,t) between the and equity and ETF returns is defined as:
αSC,t=hSCthstkt
(8)
4.
Discussion of results
As mentioned in the introduction, this paper aims to evaluate the hedging effectiveness of financial innovations in precious metals market (i.e. the market for investment in exchange traded funds for gold, silver, platinum and palladium) against the risk associated with the Asia-Pacific financial markets during the COVID-19 pandemic. Therefore, we mainly discuss the results of the optimal portfolio weights (OPW) and optimal hedge ratios (OHR) in order to assess the hedging relationship between the two asset classes while the results of the VARMA-GARCH model used in calculating the OPW and OHR are available upon request. Tables 4 and 5 respectively summarize the results for OPW and OHR.
Table 4.
Optimal portfolio weights.
Full sample
Before COVID-19
During COVID-19
Gold
Silver
Platinum
Palladium
Gold
Silver
Platinum
Palladium
Gold
Silver
Platinum
Palladium
Pacific Region
0.590
0.476
0.529
0.462
0.591
0.463
0.525
0.493
0.511
0.403
0.458
0.426
Australia
0.591
0.575
0.613
0.275
0.593
0.461
0.613
0.328
0.547
0.530
0.489
0.543
Canada
0.505
0.671
0.522
0.357
0.517
0.484
0.569
0.451
0.526
0.511
0.518
0.524
China
0.471
0.374
0.519
0.550
0.527
0.528
0.525
0.326
0.547
0.469
0.525
0.650
Hong Kong
0.490
0.464
0.505
0.378
0.512
0.443
0.569
0.389
0.539
0.491
0.517
0.645
India
0.460
0.452
0.672
0.439
0.485
0.334
0.517
0.451
0.026
0.130
Indonesia
0.454
0.472
0.419
0.282
0.481
0.421
0.621
0.261
0.532
0.521
0.522
0.637
Japan
0.503
0.469
0.498
0.470
0.497
0.447
0.500
0.438
0.510
0.481
0.506
0.484
South Korea
0.496
0.079
0.443
0.371
0.513
0.384
0.502
0.392
0.558
0.507
0.524
0.511
Malaysia
0.492
0.470
0.499
0.502
0.493
0.507
0.496
0.515
0.512
0.482
0.430
0.505
Philippines
0.498
0.295
0.506
0.464
0.511
0.514
0.528
0.528
0.530
0.493
0.519
0.591
Singapore
0.471
0.598
0.430
0.341
0.505
0.476
0.527
0.491
0.555
0.492
0.516
0.483
Thailand
0.519
0.504
0.512
0.496
0.518
0.486
0.528
0.456
0.543
0.524
0.505
0.518
Taiwan
0.475
0.479
0.471
0.431
0.497
0.511
0.522
0.534
0.553
0.506
0.492
0.654
Note: The table reports average optimal portfolio weights (OPW) in an equity and precious metals ETFs investment portfolio.
Regardless of the data sample, the estimated optimal portfolio weights show positive portfolio weight of each of the precious metals' financial innovations in a portfolio combination with the Asia-Pacific equities. Using the data sample during COVID-19, the estimated results show that financial innovations in gold, silver, platinum and palladium respectively have OPW of 0.511, 0.408, 0.458 and 0.426, respectively. The OPW estimate indicates, for instance, that the proportion of financial innovation in gold to be held in a fund portfolio combination that combines gold and Asia Pacific equity is about 51%. Like the COVID-19 sample, the results for the full sample and the pre-COVID-19 sample also show that financial innovation in gold maintains an outperformance over the three other precious metals considered, including silver, platinum and palladium. This evidence aligns with the recent studies examining the hedging prowess of gold against risk associated with the travel and tourism sector (Sikiru and Salisu, 2021) and crude oil market (Salisu et al., 2020) during the COVID-19 pandemic. The results suggest that irrespective of the post-crisis volatilities, having gold ETF in equities provides a portfolio option that provides more percentage of optimality than either silver, platinum, or palladium. The OPW results also show that the silver outperforms platinum, while platinum performs better than palladium. The results are true for the three data samples-full, pre-COVID and COVID sample periods.
Conversely, the results of the OHRs are negative for gold across the three sub-samples, but otherwise for silver, platinum, and palladium. Following Baur and Lucey (2010), when there is a negative correlation between two assets within a given portfolio, which could also be represented with the hedge ratios, it provides an indication of hedging. By implication, these results suggest that financial innovation in gold provides effective and suitable hedge for Asia-Pacific equities. However, the absolute values of the OHR show declines during the COVID-19 period compared to the estimates for the pre-COVID sample. This implies that the hedging effectiveness of gold for equities declines during the COVID-19 period for the Asia-Pacific region and all the countries considered. Similar diminishing effectiveness of gold as a hedging tool during crisis is also found by Kumar (2014) and Shrydeh et al. (2019).
In passing, we appraise the findings on the basis of the contributions of the study argued in the introductory section. First, the choice of the Asia-Pacific markets explored for the pandemic risks appears to be supported by the findings obtained from the OHR of the countries. The findings show identical results across the competing hedging securities and the data samples; full, pre-COVID and COVID-19 samples. Our results appear to also indicate that pandemic-induced financial crisis cut across all the Asia-Pacific markets as also witnessed during the previous Asian crisis and the global financial crisis (Kim, 2005; Liu, 2014; Hengchao and Hamid, 2015; Lin, 2015; Chow, 2017; Ahmed and Huo, 2019). Additionally, although we are unable to show that financial innovations in precious metals (as a whole) possess hedging effectiveness to shield investors in the stock markets under consideration, we however confirm the ability to provide investment alternative for financial innovation in gold as previously found for physical gold (Beckmann et al., 2018; Salisu et al., 2019; Huynh, 2020). Consequently, we establish that the ability of financial innovations in precious metals to hedge various market risks may well be limited to gold as also obtained by Lau et al. (2017) and Cheng et al. (2018) against oil market and currency market risks.
5.
Conclusions
In this study, we assess whether financial innovations in precious metals i.e. funds containing passive investment in precious metals (contrary to direct investment in the indexes containing physical precious metals) can provide good hedges against risks associated with the Asia-Pacific equities, before and during the unprecedented global pandemic (COVID-19). We motivate the study for the economic consequences of the pandemic in the Asia-Pacific stock markets given past incidences of financial crises (for example, the 1997 Asian crisis and the 2007/2008 global financial crisis) that have resonated shock spillovers across the region in the past. We also justify the role of financial innovations in precious metals for hedging effectiveness given the flexibility of the alternative investment funds to serve as diversified investment portfolio which could be traded as a single stock and also has the advantage of eliminating the need for investors to physically hold commodities (i.e. precious metals) and worry about storage concerns.
We collect daily prices of four prominent precious metals ETFs (as the proxy for financial innovations in the precious metals) including gold, silver, platinum and palladium alongside equity prices of the Asia-Pacific region as well as 13 country-specific equity prices. We compute the optimal portfolio weights and optimal edge ratios based on the estimates of conditional variance and covariance obtained from the VARMA-GARCH model which is suitable for tracing spillover transmissions between or among financial markets. While the results vary for the considered precious metals, the overarching evidence suggests that combining gold ETFs in an Asia-Pacific equity portfolio would provide both a valuable portfolio combination that could improve the risk-adjusted performance and provide premium for investors in addition to serving as an effective hedge for equity-related risks. Similar optimal portfolio performance is established for the three other precious metals considered, silver, platinum, and palladium. However, each of the precious metals financial innovations outperforms the others as listed, respectively.
In all, we arrive at three major conclusions. One, we demonstrate that the best outcome in terms of the ability of precious metals' financial innovations to hedge financial market risks can be realized using the financial innovation in gold as previously established for physical gold in the extant literature. In other words, the use of financial innovations in silver, platinum, and palladium as hedges for risks associated with Asia Pacific equities is less desirable compared to gold. Two, the hedging effectiveness of gold as well as other precious metals suffers a decline during the COVID-19 pandemic. This contrasts with the full sample period and the period before the pandemic. An extension of this study that accommodates more emerging and developed stock markets in other regions including the OECD countries would offer a broader perspective for meaningful generalizations.
Acknowledgement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Conflict of interest
All authors declare no conflicts of interest in this paper.
Ethics declaration
There are no ethical issues to declare in this paper.
References
[1]
H. T. Banks, S. Hu and W. C. Thompson, Modeling and Inverse Problems in the Presence of Uncertainty, SCRC Press, Boca Raton, Fl, 2014.
[2]
H. J. Clewell III, M. B. Reddy, T. Lave and M. E. Andersen, Physiologically based pharmacokinetic modeling, in Preclinical Development Handbook: ADME Biopharmaceutical Properties (ed. S. C. Gad), Wiley-Interscience, John Wiley & Sons, Inc., (2008), 1167–1127.
[3]
G. de Simone, R. B. Devereux, S. R. Daniels, G. Mureddu, M. J. Roman, T. R. Kimball, R. Greco, S. Witt and F. Contaldo, Stroke volume and cardiac output in normotensive children and adults: assessment of relations with body size and impact of overweight, Circulation, 95 (1997), 1837– 1843.
[4]
P. Deeurenberg, J. A. Weststrate and J. C. Seidell, Body mass index as a measure of body fatness: age- and sex-specific prediction formulas, Br. J. Nutr., 65 (1991), 105–114.
[5]
P. Fuster-Parra, M. Bennasar-Veny, P. Tauler, A. Ya˜nez, A. A. L´opez-Gonz´alez and A. Aguil´o, A comparison between multiple regression models and CUN-BAE equation to predict body fat in adults, PLoS ONE, 10 (2015), 1–13.
[6]
P. C. Fuchs, A. L. Barry and S. D. Brown, In vitro activities of ertapenem (mk-0826) against clinical bacterial isolates from 11 north american medical centers, Antimicrob. Agents Ch., 45 (2001), 1915–1918.
[7]
M. L. Joyner, C. C. Manning, W. Forbes, M. Maiden and A. N. Nikas, A physiologically based pharmacokinetic model for the antibiotic ertapenem, Math. Biosci. Eng., 13 (2016), 119–133.
[8]
W. J. Jusko, Pharmacokinetics of capacity-limited systems, J. Clin. Pharmacol., 29 (1989), 488– 493.
[9]
H. Kvist, B. Chowdhury, U. Grangår, U. Tylen and L. Sjöström, Total and visceral adipose tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations, Am. J. Clin. Nutr., 48 (1988), 1351–1361.
[10]
A. K. Majumdar, D. G. Musson, K. L. Birk, C. J. Kitchen, S. Holland, J. McCrea, G. Mistry, M. Hesney, L. Xi, S. X. Li, R. Haesen, R. A. Blum, R. L. Lins, H. Greenberg, S.Waldman, P. Deutsch and J. D. Rogers, Pharmacokinetics of ertapenem in healthy young volunteers, ASM, 46 (2002), 3506–3511.
[11]
Merck & Co. Inc., Highlights of Prescribing Information, Invanz®(ertapenem for injection), 2012.
[12]
D. Nix, A. Majumdar and M. DiNubile, Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians, J. Antimicrob. Chemoth., 53 (2004), ii23–ii28.
[13]
S. Pilari and W. Huisinga, Lumping of physiologically-based pharmacokinetic models and a mechanistic derivation of classical compartmental models, J. Pharmacokinet. Phar., 37 (2010), 365–405.
[14]
D. Plowchalk and J. Teeguarden, Development of a physiologically based pharmacokinetic model for estradiol in rats and humans: A biologically motivated quantitative framework for evaluating responses to estradiol and other endocrine-active compounds, Toxicol. Sci., 69 (2002), 60–78.
[15]
P. Price, R. Conolly, C. Chaisson, E. Gross, J. Young, E. Mathis and D. Tedder, Modeling interindividual variation in physiological factors used in PBPK models of humans, Crit. Rev. Toxicol., 33 (2003), 469–503.
[16]
P. M. Shah and R. D. Isaacs, Ertapenem, the first of a new group of carbapenems, J. Antimicrob. Chemoth., 52 (2003), 538–542.
[17]
B. Tummers, DataThief iii, Available from: http://datathief.org/.
This article has been cited by:
1.
Ping Yang, Min Fan, Zhiyi Li, Jianhong Cao, Xue Wu, Desheng Wu, Zhixi Lu,
Digital finance, spatial spillover and regional innovation efficiency: New insights from China,
2022,
30,
2688-1594,
4635,
10.3934/era.2022235
2.
Syed Ali Raza, Amna Masood, Ramzi Benkraiem, Christian Urom,
Forecasting the volatility of precious metals prices with global economic policy uncertainty in pre and during the COVID-19 period: Novel evidence from the GARCH-MIDAS approach,
2023,
120,
01409883,
106591,
10.1016/j.eneco.2023.106591
3.
Bayu Adi Nugroho,
Asia-Pacific Islamic Stocks and Gold: A Markov-switching Copula Estimation,
2022,
3,
2652-8681,
10.46557/001c.29949
4.
Xu Gong, Jun Xu,
Geopolitical risk and dynamic connectedness between commodity markets,
2022,
110,
01409883,
106028,
10.1016/j.eneco.2022.106028
5.
Fenghua Wen, Haocen Zhao, Lili Zhao, Hua Yin,
What drive carbon price dynamics in China?,
2022,
79,
10575219,
101999,
10.1016/j.irfa.2021.101999
6.
Isabelle Cadoret, Jacques Minlend, Tovonony Razafindrabe,
Uncertainty diffusion across commodity markets,
2022,
0003-6846,
1,
10.1080/00036846.2022.2129041
7.
Umer Shahzad, Kamel Si Mohammed, Sunil Tiwari, Joanna Nakonieczny, Renata Nesterowicz,
Connectedness between geopolitical risk, financial instability indices and precious metals markets: Novel findings from Russia Ukraine conflict perspective,
2023,
80,
03014207,
103190,
10.1016/j.resourpol.2022.103190
8.
Jianbai Huang, Xuesong Dong, Jinyu Chen, Meirui Zhong,
Do oil prices and economic policy uncertainty matter for precious metal returns? New insights from a TVP-VAR framework,
2022,
78,
10590560,
433,
10.1016/j.iref.2021.12.010
9.
Cai Yang, Xinyi Wang, Wang Gao,
Is Bitcoin a better hedging and safe-haven investment than traditional assets against currencies? Evidence from the time-frequency domain approach,
2022,
62,
10629408,
101747,
10.1016/j.najef.2022.101747
10.
Bayu Adi Nugroho,
The best-fitting model(s) of equal risk contribution: evidence from environmental-friendly portfolio,
2022,
18,
1743-9132,
756,
10.1108/IJMF-09-2021-0435
11.
Yan Zheng, Hua Yin, Min Zhou, Wenhua Liu, Fenghua Wen,
Impacts of oil shocks on the EU carbon emissions allowances under different market conditions,
2021,
104,
01409883,
105683,
10.1016/j.eneco.2021.105683
12.
Bin Mo, Juan Meng, Liping Zheng,
Time and frequency dynamics of connectedness between cryptocurrencies and commodity markets,
2022,
77,
03014207,
102731,
10.1016/j.resourpol.2022.102731
13.
Rongbing Xiao, Guangzhong Li, Yulan Wu,
Environmental Protection Tax and Corporate Capital Structure,
2022,
58,
1540-496X,
3416,
10.1080/1540496X.2022.2049970
14.
Xiaoqun Liu, Changrong Yang, Youcong Chao,
The Pricing of ESG: Evidence From Overnight Return and Intraday Return,
2022,
10,
2296-665X,
10.3389/fenvs.2022.927420
15.
Yaoqi Guo, Fengyuan Shi, Boqiang Lin, Hongwei Zhang,
The impact of oil shocks from different sources on China's clean energy metal stocks: An analysis of spillover effects based on a time-varying perspective,
2023,
81,
03014207,
103357,
10.1016/j.resourpol.2023.103357
16.
Marco Tronzano,
Optimal Portfolio Allocation between Global Stock Indexes and Safe Haven Assets: Gold versus the Swiss Franc (1999–2021),
2022,
15,
1911-8074,
241,
10.3390/jrfm15060241
17.
Haiwen Zhao, Miao Yu, Juan Meng, Yonghong Jiang,
Examining the Spillover Effects of Renewable Energy Policies on China’s Traditional Energy Industries and Stock Markets,
2024,
17,
1996-1073,
2563,
10.3390/en17112563
18.
Marco Tronzano,
What Drives Asset Returns Comovements? Some Empirical Evidence from US Dollar and Global Stock Returns (2000–2023),
2024,
17,
1911-8074,
167,
10.3390/jrfm17040167
19.
Virginie Terraza, Aslı Boru İpek, Mohammad Mahdi Rounaghi,
The nexus between the volatility of Bitcoin, gold, and American stock markets during the COVID-19 pandemic: evidence from VAR-DCC-EGARCH and ANN models,
2024,
10,
2199-4730,
10.1186/s40854-023-00520-3
20.
Ameet Kumar Banerjee, Ahmet Sensoy, John W. Goodell,
Volatility connectedness between geopolitical risk and financial markets: Insights from pandemic and military crisis periods,
2024,
10590560,
103740,
10.1016/j.iref.2024.103740
21.
Afees A. Salisu, Abeeb O. Olaniran, Xuan Vinh Vo,
Geopolitical risk, climate risk and financial innovation in the energy market,
2025,
315,
03605442,
134365,
10.1016/j.energy.2025.134365
22.
Richa Goel, Neeru Sidana, Anindita Bhattacharjee, Tilottama Singh, Manleenjot Kaur,
Shifting sands: how major events shape gold futures in the Indian commodity market,
2025,
13,
2332-2039,
10.1080/23322039.2025.2483867
Michele L. Joyner, Cammey Cole Manning, Whitney Forbes, Valerie Bobola, William Frazier. Modeling Ertapenem: the impact of body mass index on distribution of the antibiotic in the body[J]. Mathematical Biosciences and Engineering, 2019, 16(2): 713-726. doi: 10.3934/mbe.2019034
Michele L. Joyner, Cammey Cole Manning, Whitney Forbes, Valerie Bobola, William Frazier. Modeling Ertapenem: the impact of body mass index on distribution of the antibiotic in the body[J]. Mathematical Biosciences and Engineering, 2019, 16(2): 713-726. doi: 10.3934/mbe.2019034
Table 2.
Conditional heteroscedasticity and autocorrelation tests.
Full sample
Before COVID-19
During COVID-19
ARCH5
ARCH10
LB5
LB10
LB52
LB102
ARCH5
ARCH10
LB5
LB10
LB52
LB102
ARCH5
ARCH10
LB5
LB10
LB52
LB102
Region
22.0a
14.2a
7.9a
18.1b
122.8a
176.0a
4.1a
2.6a
3.3
4.9
21.6a
31.6a
8.0a
4.9a
11.7b
18.3b
40.4a
52.0a
Australia
55.8a
30.2a
9.8b
21.2b
334.7a
424.3a
5.5a
5.4a
9.4c
17.3b
27.3a
56.0a
18.4a
9.5a
10.8b
22.1a
84.4a
101.0a
Canada
20.5a
12.1a
9.7b
14.3
131.6a
222.4a
1.8
3.4a
0.5
7.3
9.3
40.5a
6.3a
3.3a
11.1b
16.0c
35.3a
50.1a
China
1.8
1.4
4.3
10.0
10.1c
14.5
2.0c
1.6
0.9
6.5
10.2c
16.5c
0.9
1.1
5.8
7.4
5.6
7.5
Hong Kong
3.4a
2.5a
4.5
9.1
19.6a
28.7a
5.0a
2.9a
1.5
4.0
23.7a
27.9a
1.6
2.0b
3.3
7.8
9.6c
14.4
India
1.6
0.9
11.9b
20.8b
9.0
10.8
0.1
0.1
1.9
5.5
0.3
0.4
16.3a
9.5a
8.1c
18.9b
78.0a
104.9a
Indonesia
20.9a
12.4a
3.6
6.9
156.0a
262.2a
4.5a
4.2a
0.4
8.3
25.2a
53.2a
4.4a
2.6a
3.0
9.2
34.7a
53.8a
Japan
7.8a
5.7a
5.5
10.4
45.1a
78.0a
2.9b
1.6
5.8
7.4
14.9b
17.5c
6.1a
4.9a
6.5
10.4
33.5a
56.2a
South Korea
33.3a
17.7a
6.6
16.8c
194.5a
263.8a
1.1
1.1
2.2
7.1
5.7
11.8
11.5a
6.8a
6.0
13.9
61.0a
73.9a
Malaysia
0.1
0.1
3.7
8.7
0.6
0.6
0.1
0.0
10.3b
18.7b
0.3
0.4
6.2a
3.8a
16.2a
22.3a
38.1a
39.7a
Philippines
22.3a
13.5a
17.1a
23.0a
127.0a
180.4a
3.3a
1.8c
1.6
6.6
16.9a
18.6b
6.9a
4.4a
11.5b
18.6b
32.1a
43.5a
Singapore
13.7a
7.1a
7.3
12.7
81.5a
94.1a
4.3a
2.5a
8.9c
16.8c
20.7a
26.3a
13.0a
8.8a
5.5
12.0
58.5a
62.2a
Thailand
28.1a
17.4a
34.9a
49.5a
187.6a
273.1a
0.8
0.8
8.3c
18.3b
3.8
8.6
5.8a
3.8a
15.3a
19.9b
38.0a
51.3a
Taiwan
4.4a
3.1a
7.7c
15.1c
27.1a
39.5a
4.4a
2.6a
4.7
15.1c
20.6a
26.8a
5.3a
4.2a
10.8b
15.9c
29.9a
36.6a
Commodities
Gold
13.1a
6.6a
3.7
6.5
62.4a
72.6a
11.8a
5.9a
5.9
10.3
562a
64.0a
3.9a
2.6a
8.0c
10.8
13.8b
19.7b
Silver
10.1a
5.9a
3.7
5.9
54.0a
79.3a
13.5a
7.3a
2.3
6.8
57.8a
76.2a
0.6
0.6
5.4
11.9
3.2
6.2
Platinum
6.4a
3.2a
6.0
6.4
35.4a
37.4a
7.0a
3.5a
3.0
5.2
33.9a
34.2a
0.5
0.3
7.6
9.4
3.3
3.7
Palladium
2.9b
4.5a
13.9a
20.5b
16.1a
53.1a
0.8
1.5
10.3b
13.8
4.2
15.0
0.3
0.6
9.3c
13.1
1.8
8.1
Note: ARCH5 and ARCH10 of conditional heteroscedasticity indicate the ARCH LM tests at 5 and 10 lags respectively. The LB and LB2 of autocorrelations follow the Ljung-Box tests conducted at 5 and 10 lags. The null hypothesis for the ARCH LM test is that the series has no ARCH effects (that is, it is not volatile) while LB test for null hypothesis is that the series is not serially correlated. The superscripts a, b and c indicate statistical significance respectively at 1%, 5% and 10% levels.
Note: ES test is the Engle-Sheppard CCC χ22 test. The superscripts a, b and c respectively indicate statistical significance for 1%, 5% and 10% levels; Region denotes the Asia-Pacific Region Equity; AUS is an acronym for Australia; CAN for Canada; CHN: China, HNK: Hong Kong; IND: India; IDN: Indonesia; JPN: Japan; KOR: South Korea; MLY: Malaysia; PHI: Philippines; SGP: Singapore, THA: Thailand; and TWN: Taiwan. The precious metals ETFs are abbreviated as GLD, SLV, PLT and PLD, respectively denoting Gold, Silver, Platinum and Palladium.
Note: ARCH5 and ARCH10 of conditional heteroscedasticity indicate the ARCH LM tests at 5 and 10 lags respectively. The LB and LB2 of autocorrelations follow the Ljung-Box tests conducted at 5 and 10 lags. The null hypothesis for the ARCH LM test is that the series has no ARCH effects (that is, it is not volatile) while LB test for null hypothesis is that the series is not serially correlated. The superscripts a, b and c indicate statistical significance respectively at 1%, 5% and 10% levels.
Period
Tests
Region
AUS
CAN
CHN
HNK
IND
IDN
JPN
KOR
MLY
PHI
SGP
THA
TWN
GLD
SLV
PLT
PLD
Full sample
Sign Bias
0.01
1.26
0.31
0.15
0.51
0.27
2.46b
1.12
0.66
0.59
0.50
0.25
1.60
1.14
1.61
0.20
2.29b
1.11
Negative Bias
0.36
0.50
0.43
0.20
0.64
0.13
0.90
0.35
0.29
0.93
0.34
0.48
0.49
0.52
0.89
0.25
0.63
0.08
Positive Bias
1.31
0.41
1.47
1.02
0.91
0.42
0.38
1.73c
1.45
0.75
0.45
1.64
1.46
0.88
0.64
0.10
1.55
0.88
Joint Bias
2.38
3.45
5.95
1.48
1.35
0.24
10.56b
3.14
2.31
1.49
0.34
3.15
3.11
4.78
5.62
0.07
5.78
1.55
Engle-Shephard
GLD
0.45
0.01
0.06
0.01
0.01
0.06
0.24
0.18
0.06
0.49
2.11
0.01
0.23
0.26
SLV
1.84
0.49
0.35
1.09
2.11
0.57
0.07
0.61
1.10
0.87
0.01
0.20
0.45
1.74
PLT
0.04
0.00
0.27
0.16
0.14
0.91
0.08
0.01
0.04
0.30
0.23
0.11
0.07
0.08
PLD
0.37
6.56b
0.63
0.73
1.98
2.37
3.97
1.13
4.41
0.09
1.14
4.61c
2.06
4.52
Before COVID-19
Sign Bias
0.17
1.09
0.38
0.33
0.32
0.37
1.44
1.03
0.22
0.84
0.05
0.01
1.64
1.69c
1.07
0.91
1.92c
0.01
Negative Bias
0.33
0.46
0.40
0.44
1.14
0.18
0.24
0.09
0.02
0.98
0.70
0.35
0.60
0.63
0.85
0.79
0.36
0.66
Positive Bias
1.12
0.24
0.93
1.60
0.91
0.59
0.47
1.60
0.81
0.73
0.28
1.44
1.47
0.45
1.02
0.74
1.20
0.74
Joint Bias
1.50
2.25
3.50
3.71
2.95
0.42
6.64c
2.61
1.48
1.50
1.11
2.71
3.23
5.88
4.44
2.77
4.27
0.99
Engle-Shephard
GLD
1.30
0.13
0.12
0.00
0.36
0.92
0.74
0.00
0.57
1.09
0.03
0.02
0.13
SLV
0.71
0.24
0.06
0.51
0.70
0.90
0.02
0.37
0.20
0.34
0.19
0.00
0.37
0.65
PLT
0.02
0.46
0.19
0.00
0.18
0.00
0.00
0.01
0.13
0.13
0.44
0.23
0.12
PLD
0.25
1.22
0.67
0.66
0.38
0.82
0.01
0.42
0.05
0.11
0.86
0.69
0.52
During COVID-19
Sign Bias
0.81
0.38
0.41
0.02
0.69
0.54
0.24
0.79
1.37
0.04
1.00
0.67
0.43
1.41
0.81
1.08
1.43
2.22**
Negative Bias
1.68
0.33
0.25
0.48
0.32
0.44
0.72
0.17
0.34
0.53
0.42
0.36
0.23
0.13
1.68c
0.54
0.60
1.13
Positive Bias
0.66
0.77
1.38
0.20
0.62
1.70c
0.94
0.33
1.67c
0.21
0.34
0.97
0.52
1.58
0.66
0.30
1.38
0.90
Joint Bias
4.04
1.69
3.99
0.32
0.90
3.09
1.69
2.47
3.10
0.51
2.18
1.20
0.42
2.84
4.04
1.89
2.52
4.93
Engle-Shephard
GLD
1.12
0.42
0.08
0.22
0.99
0.11
0.22
0.65
1.76
0.00
4.87c
0.18
2.35
1.16
SLV
3.21
7.00b
3.75
0.87
1.52
0.65
0.56
3.48
2.50
2.07
0.50
1.31
0.04
5.44c
PLT
0.44
0.54
0.02
0.66
1.04
0.30
0.03
0.65
0.26
0.46
0.17
0.31
0.00
0.85
PLD
3.25
5.10c
0.01
4.69c
7.86b
2.06
3.48
5.06c
8.31b
0.27
1.43
3.53
1.97
8.10b
Note: ES test is the Engle-Sheppard CCC χ22 test. The superscripts a, b and c respectively indicate statistical significance for 1%, 5% and 10% levels; Region denotes the Asia-Pacific Region Equity; AUS is an acronym for Australia; CAN for Canada; CHN: China, HNK: Hong Kong; IND: India; IDN: Indonesia; JPN: Japan; KOR: South Korea; MLY: Malaysia; PHI: Philippines; SGP: Singapore, THA: Thailand; and TWN: Taiwan. The precious metals ETFs are abbreviated as GLD, SLV, PLT and PLD, respectively denoting Gold, Silver, Platinum and Palladium.
Full sample
Before COVID-19
During COVID-19
Gold
Silver
Platinum
Palladium
Gold
Silver
Platinum
Palladium
Gold
Silver
Platinum
Palladium
Pacific Region
0.590
0.476
0.529
0.462
0.591
0.463
0.525
0.493
0.511
0.403
0.458
0.426
Australia
0.591
0.575
0.613
0.275
0.593
0.461
0.613
0.328
0.547
0.530
0.489
0.543
Canada
0.505
0.671
0.522
0.357
0.517
0.484
0.569
0.451
0.526
0.511
0.518
0.524
China
0.471
0.374
0.519
0.550
0.527
0.528
0.525
0.326
0.547
0.469
0.525
0.650
Hong Kong
0.490
0.464
0.505
0.378
0.512
0.443
0.569
0.389
0.539
0.491
0.517
0.645
India
0.460
0.452
0.672
0.439
0.485
0.334
0.517
0.451
0.026
0.130
Indonesia
0.454
0.472
0.419
0.282
0.481
0.421
0.621
0.261
0.532
0.521
0.522
0.637
Japan
0.503
0.469
0.498
0.470
0.497
0.447
0.500
0.438
0.510
0.481
0.506
0.484
South Korea
0.496
0.079
0.443
0.371
0.513
0.384
0.502
0.392
0.558
0.507
0.524
0.511
Malaysia
0.492
0.470
0.499
0.502
0.493
0.507
0.496
0.515
0.512
0.482
0.430
0.505
Philippines
0.498
0.295
0.506
0.464
0.511
0.514
0.528
0.528
0.530
0.493
0.519
0.591
Singapore
0.471
0.598
0.430
0.341
0.505
0.476
0.527
0.491
0.555
0.492
0.516
0.483
Thailand
0.519
0.504
0.512
0.496
0.518
0.486
0.528
0.456
0.543
0.524
0.505
0.518
Taiwan
0.475
0.479
0.471
0.431
0.497
0.511
0.522
0.534
0.553
0.506
0.492
0.654
Note: The table reports average optimal portfolio weights (OPW) in an equity and precious metals ETFs investment portfolio.
Full sample
Before COVID-19
During COVID-19
Gold
Silver
Platinum
Palladium
Gold
Silver
Platinum
Palladium
Gold
Silver
Platinum
Palladium
Pacific Region
−0.094
0.101
0.165
0.240
−0.106
0.105
0.168
0.227
−0.031
0.114
0.205
0.189
Australia
−0.078
0.088
0.117
0.326
−0.079
0.108
0.112
0.290
−0.044
0.150
0.151
0.195
Canada
−0.060
0.110
0.178
0.277
−0.065
0.136
0.148
0.232
−0.038
0.149
0.160
0.188
China
−0.105
0.118
0.142
0.226
−0.086
0.076
0.145
0.302
−0.020
0.135
0.173
0.194
Hong Kong
−0.085
0.118
0.156
0.308
−0.059
0.108
0.135
0.296
0.016
0.163
0.175
0.191
India
−0.076
0.088
0.107
0.226
−0.065
0.111
0.113
0.223
−0.210
0.250
0.074
0.218
Indonesia
0.043
0.192
0.287
0.320
0.023
0.222
0.189
0.327
0.037
0.193
0.239
0.150
Japan
−0.128
0.031
0.117
0.195
−0.127
0.027
0.089
0.203
−0.032
0.094
0.154
0.215
South Korea
−0.093
0.352
0.171
0.269
−0.093
0.163
0.158
0.257
−0.037
0.169
0.149
0.205
Malaysia
−0.043
0.120
0.169
0.161
−0.059
0.040
0.158
0.163
0.001
0.147
0.208
0.135
Philippines
−0.012
0.214
0.196
0.246
−0.011
0.128
0.149
0.221
0.055
0.217
0.196
0.188
Singapore
−0.092
0.080
0.203
0.351
−0.062
0.058
0.114
0.267
−0.052
0.099
0.151
0.243
Thailand
0.029
0.211
0.256
0.261
0.074
0.188
0.221
0.303
0.043
0.192
0.280
0.245
Taiwan
−0.072
0.124
0.167
0.223
−0.099
0.068
0.085
0.207
−0.010
0.171
0.206
0.152
Note: The table reports average optimal hedge ratios (OHR) in an equity and precious metals ETFs investment portfolio.
Figure 2. Plot of BMI versus volume of the fat using Equation (4) and Equations (5) and (6). The black circle is representative of the calculation done for the original normal height, normal weight male
Figure 3. Simulation of Equations (1)–(3) using optimal IWLS parameter values given in Table 3. Plot (a) illustrates the total concentration CBl. Plot (b) illustrates the free concentration CBf
Figure 4. Amount of Ertapenem in the Fat in normal height, normal weight males and females
Figure 5. Plot (a) illustrates the total concentration CBl in normal height, normal weight males and females. Plot (b) illustrates the free concentration CBf in normal height, normal weight males and females
Figure 6. Area under the Total Concentration Curve of Ertapenem in the Blood. Plot (a) illustrates the distribution of AUC for males; the solid black vertical line represents the AUC for the original normal height, normal weight male. Plot (b) illustrates the distribution of AUC for females
Figure 7. Area under the Free Concentration Curve of Ertapenem in the Blood. Plot (a) illustrates the distribution of AUC for males; the dashed black horizontal line represents the AUC for the original normal height, normal weight male. Plot (b) illustrates the distribution of AUC for females
Figure 8. Minimum Free Concentration Curve of Ertapenem in the Blood. Plot (a) illustrates the distribution for males; the dashed black horizontal line represents the minimum free concentration for the original normal height, normal weight male. Plot (b) illustrates the distribution for females
Figure 9. Peak Total Concentration Curve of Ertapenem in the Blood. Plot (a) illustrates the distribution for males; the dashed black horizontal line represents the peak total concentration for the original normal height, normal weight male. Plot (b) illustrates the distribution for females
Figure 10. Percent of Dose of Ertapenem in the Fat. Plot (a) illustrates the percent for males; the solid black line represents the percent for the original normal height, normal weight male. Plot (b) illustrates the percent for females
Figure 11. Half-life of ertapenem in males (M) and females (F) of different BMI classifications; the black star represents the half-life for the original normal height, normal weight male